FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Luitpold Pharmaceuticals Concentrated Sodium Chloride Injection Recall

CONCENTRATED SODIUM CHLORIDE INJECTION, USP, 23

Luitpold Pharmaceuticals, Inc. · Shirley, NY

Risk level
Class II
Reported by FDA
Jun 20, 2012
Recall ID
D-1378-2012
Check your lot numberHow we source this data

Summary

Luitpold Pharmaceuticals recalled Concentrated Sodium Chloride Injection starting Mar 15, 2011. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1378-2012 on Jun 20, 2012. Reason: Presence of Particulate Matter: In the course of inspecting retention samples visual particles were observed. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: In the course of inspecting retention samples visual particles were observed.

Product description

CONCENTRATED SODIUM CHLORIDE INJECTION, USP, 23.4% a) 30 mL SINGLE DOSE VIAL, (NDC 0517-2930-25), b) 100 mL PHARMACY BULK PACKAGE (NDC 0517-2900-25), Rx Only, AMERICAN REGENT, INC. SHIRLEY, NY 11967.

Lot numbers, UPCs & expiration codes

30 mL Lots: 9198, 9252, 9299, 9305, 9402, 9423, 9432, 9553, 9595, 9646, 9681, 9737, 9797, 9831, 0051, 0095, 0362; 100 mL Lots: 9225, 9492, 9711, 0007, 0058

Where it was sold

Nationwide, Puerto Rico, and Abu Dhabi

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1378-2012
Classification
Class II
Status
Terminated
Recall initiated
Mar 15, 2011
FDA report date
Jun 20, 2012
Quantity
30 mL: 2,078,800 vials; 100 mL: 167,100 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Luitpold Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-1378-2012, exactly as published.

Show all FDA fields
City
Shirley
State
NY
Status
Terminated
Country
United States
Event ID
58410
Address
One Luitpold Drive
Address (line 2)
P.O. Box 9001
Code information
30 mL Lots: 9198, 9252, 9299, 9305, 9402, 9423, 9432, 9553, 9595, 9646, 9681, 9737, 9797, 9831, 0051, 0095, 0362; 100 mL Lots: 9225, 9492, 9711, 0007, 0058
Postal code
11967-9001
Report date
Jun 20, 2012
Product type
Drugs
Recall number
D-1378-2012
Classification
Class II
Recalling firm
Luitpold Pharmaceuticals, Inc.
Product quantity
30 mL: 2,078,800 vials; 100 mL: 167,100 vials
Termination date
Jun 28, 2018
Reason for recall
Presence of Particulate Matter: In the course of inspecting retention samples visual particles were observed.
Voluntary / mandated
Voluntary: Firm initiated
Product description
CONCENTRATED SODIUM CHLORIDE INJECTION, USP, 23.4% a) 30 mL SINGLE DOSE VIAL, (NDC 0517-2930-25), b) 100 mL PHARMACY BULK PACKAGE (NDC 0517-2900-25), Rx Only, AMERICAN REGENT, INC. SHIRLEY, NY 11967.
Distribution pattern
Nationwide, Puerto Rico, and Abu Dhabi
Recall initiation date
Mar 15, 2011
Initial firm notification
Press Release
Center classification date
Jun 14, 2012

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1378-2012, published Jun 20, 2012. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls